scholarly article | Q13442814 |
P50 | author | Jeff Idle | Q57972311 |
Diren Beyoğlu | Q73454803 | ||
P2093 | author name string | Ş Güniz Küçükgüzel | |
Adrian Keogh | |||
Sevil Şenkardeş | |||
P2860 | cites work | Metabolic alterations and hepatitis C: From bench to bedside | Q26773261 |
Factors associated with the response to interferon-based antiviral therapies for chronic hepatitis C | Q26825715 | ||
Sodium dependent multivitamin transporter (SMVT): a potential target for drug delivery | Q26863420 | ||
Glutathione synthetase deficiency | Q28259316 | ||
BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis | Q29617585 | ||
The epidemiological changes of HCV and HBV infections in the era of new antiviral therapies and the anti-HBV vaccine | Q30252122 | ||
Biotin uptake by human intestinal and liver epithelial cells: role of the SMVT system | Q34184789 | ||
Distinctive pharmacological differences between liver cancer cell lines HepG2 and Hep3B. | Q34962165 | ||
The current state of drug discovery and a potential role for NMR metabolomics | Q35072850 | ||
The metabolomic profile of gamma-irradiated human hepatoma and muscle cells reveals metabolic changes consistent with the Warburg effect. | Q36514148 | ||
The glycine deportation system and its pharmacological consequences. | Q36880287 | ||
Metabolomics as a Challenging Approach for Medicinal Chemistry and Personalized Medicine. | Q53054318 | ||
The mechanism of pantothenate transport by rat liver parenchymal cells in primary culture | Q70083063 | ||
Cancer metabolism: a therapeutic perspective | Q89947416 | ||
Tissue metabolomics of hepatocellular carcinoma: tumor energy metabolism and the role of transcriptomic classification. | Q36961679 | ||
Apoptosis and glutathione: beyond an antioxidant. | Q37574928 | ||
A quick look at biochemistry: carbohydrate metabolism | Q38107290 | ||
Update on hepatitis C virus resistance to direct-acting antiviral agents | Q38218790 | ||
Regulation of mammalian nucleotide metabolism and biosynthesis | Q38335072 | ||
The Crabtree and Warburg effects: Do metabolite-induced regulations participate in their induction? | Q38804967 | ||
Current status and future prospects of chemotherapy for advanced hepatocellular carcinoma | Q38843057 | ||
The plasma lipidome in acute myeloid leukemia at diagnosis in relation to clinical disease features | Q38884878 | ||
Major involvement of Na(+) -dependent multivitamin transporter (SLC5A6/SMVT) in uptake of biotin and pantothenic acid by human brain capillary endothelial cells. | Q38895031 | ||
Metabolic Hallmarks of Tumor and Immune Cells in the Tumor Microenvironment | Q39197674 | ||
Antitumor effect of SIRT1 inhibition in human HCC tumor models in vitro and in vivo. | Q39206845 | ||
Glutathione reductase plays an anti-apoptotic role against oxidative stress in human hepatoma cells | Q39725657 | ||
The chemistry, pharmacology and clinical pharmacology of diflunisal | Q39773990 | ||
Interindividual variation in gene expression responses and metabolite formation in acetaminophen-exposed primary human hepatocytes | Q40146321 | ||
Sorafenib (BAY 43-9006) inhibits tumor growth and vascularization and induces tumor apoptosis and hypoxia in RCC xenograft models | Q40198053 | ||
Cell cycle-dependent regulation of pyrimidine biosynthesis | Q40689222 | ||
Synthesis of novel diflunisal hydrazide-hydrazones as anti-hepatitis C virus agents and hepatocellular carcinoma inhibitors. | Q40860497 | ||
Accumulation of human promyelocytic leukemic (HL-60) cells at two energetic cell cycle checkpoints | Q40965797 | ||
Metabolomics reveals that aldose reductase activity due to AKR1B10 is upregulated in hepatitis C virus infection. | Q41610203 | ||
Endogenous and xenobiotic metabolic stability of primary human hepatocytes in long-term 3D spheroid cultures revealed by a combination of targeted and untargeted metabolomics | Q41870452 | ||
Dog bites man or man bites dog? The enigma of the amino acid conjugations | Q42106652 | ||
Measurements of ATP in mammalian cells | Q44021176 | ||
Potential Therapeutic Targets in Energy Metabolism Pathways of Breast Cancer | Q46393725 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Hepatitis C virus | Q708693 |
metabolic network | Q2263094 | ||
P577 | publication date | 2017-06-02 | |
P1433 | published in | Metabolites | Q27724046 |
P1476 | title | A Novel Anti-Hepatitis C Virus and Antiproliferative Agent Alters Metabolic Networks in HepG2 and Hep3B Cells | |
P478 | volume | 7 |
Search more.